Aimmune An Opportunity For Unmet Needs
August 31, 2015 at 11:01 AM EDT
Aimmune Therapeutics Inc (NASDAQ: AIMT) shares have been declining this month, after peaking at $26.63 on August 14. Credit ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.